Dld Asset Management, LP Acadia Pharmaceuticals Inc Transaction History
Dld Asset Management, LP
- $438 Million
- Q4 2024
A detailed history of Dld Asset Management, LP transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Dld Asset Management, LP holds 217,600 shares of ACAD stock, worth $3.93 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
217,600Holding current value
$3.93 Million% of portfolio
0.5%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding ACAD
# of Institutions
316Shares Held
164MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$775 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$252 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$218 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$157 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$132 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.93B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...